Two Dose Epidural Morphine for Post-cesarean Analgesia

Overview

The investigators aim to assess the analgesic effect of a two-dose epidural morphine regimen for 2nd day post-cesarean pain, as part of a multimodal analgesia regimen, which includes scheduled Nonsteroidal anti-inflammatory drugs (NSAIDs). The investigators hypothesize that administration of a second dose of epidural morphine 3 mg, 24 hours after an initial intraoperative dose, will provide superior post-cesarean analgesia during the 2nd 24 hours after surgery, compared to a single epidural morphine dose regimen. The primary outcome will be the amount of intravenous morphine patients self-administer during the 2nd 24 hours post-surgery.

Study Type

  • Study Type: Interventional
  • Study Design
    • Allocation: Randomized
    • Intervention Model: Parallel Assignment
    • Primary Purpose: Treatment
    • Masking: Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)
  • Study Primary Completion Date: June 2014

Detailed Description

This will be a randomized, double-blinded placebo-controlled study. In this study, women who underwent cesarean section with epidural anesthesia will receive 3 mg of epidural morphine intraoperatively, and have the epidural catheter left in place. Patients will be randomized to receive either epidural saline or epidural morphine 3 mg at 18 – 24 hours after the first dose of epidural morphine, following which the epidural catheter will be removed. It is standard of care at our institution for women undergoing cesarean section with epidural anesthesia to receive epidural morphine 3 mg. What is not typically carried out is to give a second dose of epidural morphine 3mg. The randomization will be carried out by a computerized block randomization table; the proportion for the 2 groups will be 1:1. The primary outcome will be the amount of intravenous morphine patients self-administer in the second 24 hours after surgery. Secondary outcomes will include pain scores every 6 hours, satisfaction with analgesia, side effects (itching, nausea/vomiting).

Interventions

  • Drug: Epidural Morphine
    • Patients will be given 3mg epidural morphine, 24 hours after the initial dose.
  • Drug: Epidural Saline
    • Patients will be given epidural saline 6ml, 24 hours after receiving epidural morphine 3 mg.

Arms, Groups and Cohorts

  • Active Comparator: Epidural Morphine
    • Group receiving 3mg epidural morphine, 24 hours after the initial dose
  • Placebo Comparator: Epidural Saline
    • Group receiving epidural saline 6ml, 24 hours after receiving epidural morphine 3mg.

Clinical Trial Outcome Measures

Primary Measures

  • The Average Amount of Intravenous Morphine Patients Self-administered in the Second 24 Hours Post-surgery
    • Time Frame: Up to 48 hours post-operatively
    • The primary outcome of this study is the amount (mg) of morphine self-administered by PCA pump during the second 24 hours after surgery. This will be compared by unpaired t-test for two groups.

Participating in This Clinical Trial

Inclusion Criteria

  • Women undergoing cesarean section under epidural anesthesia. Exclusion Criteria:

  • Emergent cesarean section – Coagulopathy – Failed epidural anesthesia or patchy block – General anesthesia – Use of epidural chloroprocaine – Allergy or contraindication to Non-steroidal anti-inflammatory drug (NSAIDs) – Severe opioid side effects – History of chronic opioid use – History of chronic pain – History of obstructive sleep apnea – Morbid obesity (Body Mass Index (BMI)>45 kg/m2) – Height under 4' 10" (147 cm) – Documented dural puncture by the epidural (Tuohy) needle – Preeclampsia – Other significant medical disease (American Society of Anesthesiologists (ASA) 3 or more).

Gender Eligibility: Female

Minimum Age: 18 Years

Maximum Age: 45 Years

Are Healthy Volunteers Accepted: No

Investigator Details

  • Lead Sponsor
    • Columbia University
  • Provider of Information About this Clinical Study
    • Principal Investigator: Allison Lee, Assistant Professor of Anesthesiology – Columbia University
  • Overall Official(s)
    • Allison Lee, MD, Principal Investigator, Columbia University

References

Zakowski MI, Ramanathan S, Turndorf H. A two-dose epidural morphine regimen in cesarean section patients: pharmacokinetic profile. Acta Anaesthesiol Scand. 1993 Aug;37(6):584-9. doi: 10.1111/j.1399-6576.1993.tb03769.x.

Palmer CM, Nogami WM, Van Maren G, Alves DM. Postcesarean epidural morphine: a dose-response study. Anesth Analg. 2000 Apr;90(4):887-91. doi: 10.1097/00000539-200004000-00021.

Clinical trials entries are delivered from the US National Institutes of Health and are not reviewed separately by this site. Please see the identifier information above for retrieving further details from the government database.

At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.